The cost of Anoro (umeclidinium and vilanterol) for Medicare beneficiaries can vary depending on several factors, including the specific Medicare plan, the pharmacy, and whether a generic version is available.
What is Anoro, and what does it treat?
Anoro is a prescription medication used for the long-term treatment of airflow obstruction in people with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema [1]. It is a combination inhaler containing two active ingredients: umeclidinium, a long-acting muscarinic antagonist (LAMA), and vilanterol, a long-acting beta2-adrenergic agonist (LABA) [1].
How does Medicare cover Anoro?
Medicare Part D, the prescription drug benefit program, generally covers Anoro. However, the exact out-of-pocket cost will depend on your specific Part D plan's formulary (list of covered drugs), deductible, copayment, and coinsurance [2]. It is important to check your plan's formulary or contact your plan provider to understand your coverage for Anoro.
What is the typical out-of-pocket cost for Anoro with Medicare?
Without specific plan details, it is difficult to state a precise cost. However, the average retail price for a 30-day supply of Anoro Ellipta can range from $400 to over $500 [3]. Medicare beneficiaries may pay significantly less than this retail price, depending on their plan's cost-sharing structure. Many Medicare Part D plans place Anoro in Tier 3 or Tier 4, which typically involve higher copayments or coinsurance compared to lower tiers [2].
Are there ways to reduce the cost of Anoro for Medicare patients?
Several options may help reduce the cost of Anoro for Medicare patients:
* Manufacturer Coupons and Patient Assistance Programs: While these programs are often geared towards commercially insured patients, some may offer assistance to those with Medicare, especially if they meet certain income requirements. It is advisable to check the Anoro manufacturer's website for any available savings programs.
* Generic Availability: As of now, a generic version of Anoro is not available, which can contribute to higher costs [4].
* Pharmacy Choice: Costs can differ between pharmacies. Comparing prices at different pharmacies, including mail-order pharmacies, may reveal savings.
* Medicare Plan Comparison: If Anoro is particularly expensive under your current Medicare Part D plan, exploring other Part D plans during the annual enrollment period could lead to lower costs for this medication.
When does Anoro's patent expire?
The patent expiration date for Anoro is a significant factor influencing potential cost reductions through generic availability. DrugPatentWatch.com tracks patent information and can provide details on when patents for specific drugs are set to expire [5]. For Anoro (umeclidinium and vilanterol), the relevant patents and their expiration dates determine when generic manufacturers can seek approval and market their versions of the drug. Information on Anoro's patent status can be found on drugpatentwatch.com [5].
What if Anoro is not covered by my Medicare plan?
If Anoro is not listed on your Medicare Part D plan's formulary, or if the cost is prohibitive, discuss alternative treatment options with your doctor. They may be able to prescribe a different medication for COPD that is covered by your plan or is more affordable. You can also appeal your plan's decision if you believe Anoro is medically necessary and should be covered [2].
Sources:
1. https://www.anoro.com/
2. Medicare.gov
3. GoodRx.com
4. FDA Orange Book
5. https://drugpatentwatch.com/